CMS Proposal Puts Medicare Advantage Audit Recoveries in Focus
The proposed rule would extend audit findings across contracts, with CMS estimating average recoveries of about $9 billion per payment year.
Stocks2 sources
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 2 of 89
The proposed rule would extend audit findings across contracts, with CMS estimating average recoveries of about $9 billion per payment year.
Stocks2 sources
The investigation comes as US lawmakers urge a separate review of whether Nvidia customer Megaspeed diverted chips to China.
Stocks3 sources
The regulator will notify authorities about restoring voting rights and removing a trading restriction on shares held by two Tera entities.
Stocks2 sources
Ümit Özlale alleged Kiler family members sold shares through Bulls-linked transactions; the holding denied wrongdoing and said it had filed legal action.
Stocks2 sources
The French drugmaker is assessing a deal that could take weeks, as investors await an acquisition to bolster its medicine pipeline.
Stocks2 sources
The lender’s net interest margin narrowed in its first-quarter update, and it expects a modest further decline through 2027.
Stocks
The automaker also wants to cut two payments and make working hours more flexible as it prepares for negotiations with IG Metall.
Stocks3 sources
Hunterbrook disclosed a short position as it alleged China-related exposure; AMD had not immediately responded to CNBC’s request for comment.
Stocks
Palo Alto’s higher annual forecast sent its shares higher and helped drive gains across cybersecurity companies, including CrowdStrike and Fortinet.
Stocks
The bank said attackers may have accessed marketing records containing some customers’ names and email addresses, but its services were unaffected.
Stocks4 sources
Tesla delivered 810,889 vehicles from its Shanghai factory in the first 10 months of 2026, according to the report.
Stocks3 sources
The higher drug forecasts accompany a 5% annual sales-growth outlook through 2031 as investors weigh the company’s prospects beyond that year.
Stocks
The drugmaker expects annual sales growth of 5% through 2031 and raised peak sales guidance for three key medicines.
Stocks2 sources
Alok Bansal will step down on March 31, 2027, and remain on the board as a non-executive director.
Stocks
CEO Lip-Bu Tan announced the foundry customer without naming it, while Intel separately identified Microsoft for advanced packaging.
Stocks
A Wall Street Journal report says none of the pledged funding has reached AI companies, raising concerns about financing for neoclouds.
Stocks2 sources
Moody’s kept Nvidia’s Aa1 rating but lowered its outlook, citing uncertainty after Jensen Huang’s departure and potential regulatory pressures.
Stocks2 sources
Livsayis won approval for adults with anti-AChR-positive generalized myasthenia gravis, based on Phase 3 results reported by Regeneron.
Stocks
The NMPA approved SYVIK for certain adults with chronic primary ITP and warm antibody autoimmune hemolytic anemia.
Stocks
The game’s global launch is expected to support PlayStation sales, though analysts say its appeal in Japan is limited.
Stocks2 sources
The renewable-energy unit plans to use new-share sale proceeds to repay debt, while parent NLC India plans to sell 100 million shares.
Stocks
The fintech company may file as soon as next week, then begin investor roadshows and target a launch as early as February.
Stocks2 sources
The framework includes commitments on Frankfurt, jobs and Commerzbank’s small-business lending, while Berlin drops its demand for board seats.
Stocks5 sources
The company plans to remove seven Russian subsidiaries from consolidation after losing management control under temporary administration measures.
Stocks2 sources